Cancer News Archives | raah-e-aseman charity

Real-Time Genetic Test During Brain Surgery Revolutionizes Glioma Treatment

وبرایشگر سایت — Sat, 02 Aug 2025 20:42:18 +0000

In a breakthrough moment for brain cancer care, researchers funded by the National Cancer Institute (NCI) have developed a rapid genetic test capable of identifying critical mutations in glioma tumors while the patient is still in surgery. The results are delivered in less than 90 minutes, a dramatic improvement over the previous process that could take weeks.
This innovation brings real-time precision medicine directly into the operating room—giving surgeons and oncologists immediate insights to guide both surgical decisions and post-surgery treatment planning.
A Game-Changer for Glioma Patients
The test targets mutations in the IDH1 and IDH2 genes, which significantly influence how aggressive a glioma is and how it will respond to treatment.
Here’s how this test transforms care:
• Smarter Surgical Decisions: If the tumor has an IDH mutation (typically indicating slower growth), the surgeon may remove less tissue to preserve brain function. If the mutation is absent (indicating a more aggressive tumor), a more extensive resection may be warranted.
• Faster, Tailored Treatment: Real-time results mean the oncology team can immediately start planning targeted therapies, customized to the patient’s tumor biology—without weeks of delay waiting for traditional pathology reports.
A recent clinical study confirmed the test’s high accuracy and reliability, establishing it as a powerful tool for neurosurgeons and cancer specialists.
Raah-e-Aseman Foundation: A New Era in Brain Cancer Care
At the Raah-e-Aseman Charitable Foundation, we celebrate this advancement as a milestone in the mission toward personalized, compassionate cancer treatment.
This rapid test reduces not only the time to diagnosis but also the emotional toll patients face while waiting for results. It is a shining example of how modern science can directly improve patient outcomes and quality of life.
By enabling real-time, biology-informed surgical strategies, this breakthrough helps ensure that no moment in the cancer treatment journey is wasted—especially when every minute counts.
We commend the researchers, physicians, and institutions turning innovation into hope, and reaffirm our commitment to supporting cutting-edge approaches that make cancer care smarter, faster, and more human.

Source:
National Cancer Institute. (2025). During Brain Cancer Surgery, a Rapid Test Can Identify Mutations in Tumor Cells. Cancer Currents Blog.
🔗 Read the full article
.

The post Real-Time Genetic Test During Brain Surgery Revolutionizes Glioma Treatment appeared first on raah-e-aseman charity.

New Breakthrough in Breast Cancer Detection: “Stromal Disruption” Emerges as Powerful Biomarker for Aggressive Disease

وبرایشگر سایت — Sat, 02 Aug 2025 20:29:52 +0000

In a major advancement for global breast cancer research, scientists at the National Institutes of Health (NIH) have identified a new tissue-based biomarker—“stromal disruption”—that could dramatically improve how doctors detect and treat aggressive forms of breast cancer.
The research, published on May 14, 2025, in the Journal of the National Cancer Institute and highlighted in a press release from the National Cancer Institute (NCI), points to stromal disruption as a key predictive factor in both cancer development and survival outcomes.
What Is Stromal Disruption—and Why Does It Matter?
Stromal disruption refers to microscopic changes in the stroma, the connective tissue that surrounds and supports breast cells. These changes—previously undetected in traditional screenings—were analyzed using advanced machine learning, which revealed a strong correlation between disrupted stroma and:
1. Increased risk of future cancer in women with non-cancerous (benign) breast conditions.
2. Worse survival rates and more aggressive tumor types in women already diagnosed with invasive breast cancer.
A Game-Changer for Prevention and Treatment
What makes this discovery groundbreaking is its accessibility and affordability. Unlike expensive molecular tests, stromal disruption can be detected through standard tissue biopsies—making it a potentially life-saving tool in both high-income and low-resource settings.
Doctors may soon be able to:
• Identify high-risk patients long before cancer develops.
• Customize treatment plans for existing patients based on the severity and behavior of their tumors.
• Implement prevention strategies, especially in patients where inflammation may be contributing to tissue damage.
Promoting Health Equity in Cancer Care
At the Raah-e-Aseman Charitable Foundation, we see this discovery as a transformative step toward health equity in breast cancer prevention and care. Because stromal disruption can be assessed cost-effectively, it aligns perfectly with our mission to bring the latest scientific advances to all women—regardless of income, geography, or background.
The possibility of using anti-inflammatory treatments or lifestyle modifications to reverse or prevent stromal disruption also opens new pathways for cancer prevention, especially in communities with limited access to high-tech interventions.
Toward a Future of Personalized, Preventative Care
This research reinforces the importance of looking beyond cancer cells to understand the broader biological environment that supports cancer growth. By expanding the focus to include stromal tissue health, we move one step closer to early detection, targeted prevention, and personalized treatment—the future of cancer care.

Source:
Abubakar, M., et al. (2025, May 14). Unraveling the role of stromal disruption in aggressive breast cancer etiology and outcomes. Journal of the National Cancer Institute.
🔗 Read NCI Press Release
🔗 Additional Coverage at Bioengineer.org

The post New Breakthrough in Breast Cancer Detection: “Stromal Disruption” Emerges as Powerful Biomarker for Aggressive Disease appeared first on raah-e-aseman charity.

Cracking the Cancer Code: Scientists Investigate Environmental Causes Behind the Surge in Early-Onset Cancers

وبرایشگر سایت — Sat, 02 Aug 2025 20:25:28 +0000

A dramatic rise in cancer diagnoses among adults under 50—referred to as early-onset cancer—is pushing researchers worldwide to dig deeper into the underlying causes. A new report by the National Cancer Institute (NCI) is shedding light on a crucial but underexplored area: the impact of early-life environmental exposures on future cancer risk.
For years, cancer was viewed primarily as a disease of aging. But now, an alarming increase in colorectal, breast, pancreatic, and other cancers among younger adults is challenging that narrative and raising new questions about what’s fueling this disturbing trend.
What’s Inside the “Black Box”? The Role of Environmental Exposures
The NCI’s latest findings suggest that the answer lies within what scientists are calling the “black box”—a complex interaction between environmental factors and genetics, especially during early life.
Researchers now focus on the “exposome”—the sum of all environmental exposures a person experiences from conception onward. These include:
• Diet and physical activity
• Exposure to pollutants and microplastics
• Use of antibiotics and medications
• Endocrine disruptors like plastics and pesticides
Experts believe that such exposures during critical windows of development—before birth, in childhood, and adolescence—can silently program biological changes, disrupting systems like the immune response and gut microbiome, ultimately increasing cancer risk decades later.
This represents a major paradigm shift in cancer research: prevention may need to start long before symptoms appear—and even before adulthood.
Raahe Aseman Foundation: Supporting the Next Frontier of Cancer Research
At the Raah-e-Aseman Charitable Foundation, we believe this research is a turning point. Understanding the root causes of early-onset cancer is essential—not only to treat it more effectively but to prevent it in future generations.
This calls for:
• Long-term, collaborative studies that track environmental exposures over a lifetime
• Public education about environmental health risks
• Support systems for young cancer patients, who face unique challenges like career disruption, fertility loss, and the emotional toll of a disease they never expected at their age
Our mission is not only to support patients, but also to advocate for preventative action, healthy living, and investment in research that can reveal how cancer starts—and how to stop it before it begins.

Source:
National Cancer Institute. (2025). Studying a ‘Black Box’: The Environmental Factors Behind the Rise in Early-Onset Cancers. Cancer Currents Blog.
🔗 Read full article

The post Cracking the Cancer Code: Scientists Investigate Environmental Causes Behind the Surge in Early-Onset Cancers appeared first on raah-e-aseman charity.

Global Inequality in Cancer Care: New Study Reveals How Access to Healthcare Shapes Survival Rates

وبرایشگر سایت — Sat, 02 Aug 2025 20:17:51 +0000

A major new study has uncovered a harsh global reality: where you live may determine whether you survive cancer.
Published on July 23, 2025, in the International Journal of Surgery, the study analyzed cancer data from 171 countries and found a strong correlation between a nation’s healthcare infrastructure and its cancer mortality rates. In simple terms, countries with fewer doctors, nurses, hospital beds, and cancer care services suffer higher cancer-related deaths—even when the cancers are treatable.
Key Findings: Cancer Outcomes Depend on Healthcare Access
This systematic population-based analysis confirmed that in lower-income countries, survival from cancer is often compromised by:
• Lack of early and accurate diagnosis
• Limited or no access to chemotherapy, radiotherapy, or surgical oncology
• Shortages of trained medical professionals
These gaps in healthcare access mean that millions of people die each year from cancers that could have been treated—if they had been born elsewhere. The study exposes how cancer survival is not only a medical issue but a matter of economic and structural inequality.
A Wake-Up Call for Global Health Equity
At the Raah-e-Aseman Charitable Foundation, this research reinforces our belief that cancer care must be recognized as a basic human right, not a privilege reserved for the wealthy. It is unacceptable that a child diagnosed with cancer in a high-income country has a vastly better chance of survival than one born in a low-income nation.
This study provides data-backed evidence that we must invest in:
• Building and strengthening healthcare systems
• Training specialized cancer care professionals
• Expanding access to diagnostics and treatment in underserved areas
Only by addressing these structural inequalities can we close the cancer survival gap and give every person a fair chance to fight the disease.

Source:
Zhu, Q., Sun, K., Yao, Y., Li, X., Dai, M., Wei, W., Bray, F., & Zheng, R. (2025, July 23). Global Disparities in Healthcare Resources and Cancer Burden: A Population-based Systematic Analysis of 171 Countries in 2022. International Journal of Surgery. Published online ahead of print.
🔗 DOI: 10.1097/JS9.0000000000002960

The post Global Inequality in Cancer Care: New Study Reveals How Access to Healthcare Shapes Survival Rates appeared first on raah-e-aseman charity.

AI Chatbot Empowers Underserved Women to Take Control of Cervical Cancer Screening, Study Finds

وبرایشگر سایت — Sat, 02 Aug 2025 20:07:00 +0000

A new peer-reviewed study has revealed that a user-friendly AI-powered chatbot can significantly boost cervical cancer screening rates among socioeconomically disadvantaged women by helping them make informed decisions about their health.

Cervical cancer remains one of the most preventable cancers, yet many women—especially those from underserved communities—face barriers such as lack of access, low health literacy, and mistrust in the healthcare system. These obstacles contribute to stark disparities in cancer prevention and early detection.

To address this urgent public health challenge, researchers developed and validated a chatbot-based decision aid using a user-centered design approach. The tool was co-created with input from both healthcare professionals and women from vulnerable populations, ensuring it was easy to use, informative, and trustworthy.

The chatbot educates users about cervical cancer, outlines the benefits of regular screening, and introduces the option of HPV self-sampling, a convenient and less invasive test that can be done at home.

Results from the study were highly promising. Even women with limited digital literacy found the chatbot intuitive and empowering. The majority reported an increase in both knowledge and confidence, with many expressing a clear intention to schedule a screening appointment after interacting with the tool.

The Raah-e-Aseman Charitable Foundation supports this innovative approach as a transformative step toward reducing health inequalities. By using accessible technology like AI chatbots, healthcare providers can bridge information gaps, increase screening rates, and ultimately save lives.

This research underscores a powerful truth: when technology is thoughtfully designed with the end-user in mind, it can break down long-standing barriers and advance health equity in cancer prevention.

Source:
Le Bonniec, A., Sauvaget, C., Lucas, E., Nassiri, A., & Selmouni, F. (2025). Design and Validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Women Experiencing Socioeconomic Disadvantage: User-Centered Approach Study. JMIR Cancer. Published online July 24, 2025. Link to study

The post AI Chatbot Empowers Underserved Women to Take Control of Cervical Cancer Screening, Study Finds appeared first on raah-e-aseman charity.